2.Clinical observation on etimicin sulphate in the treatment of urinary tract infection combined with type 2 diabetes mellitus in women
Chinese Journal of Rehabilitation Theory and Practice 2004;10(7):441-441
目的观察硫酸依替米星治疗女性2型糖尿病合并泌尿系感染的疗效。方法60例门、急诊的女性2型糖尿病合并泌尿系感染患者应用硫酸依替米星(200mg/d)治疗7d。结果硫酸依替米星治疗女性2型糖尿病合并泌尿系感染的有效率为90%(54/60)。结论硫酸依替米星是治疗女性2型糖尿病合并泌尿系感染的有效药物。
3.The clinical characteristics and prevention of asymptomatic bacteriuria in women patients with type 2 diabetes
Chinese Journal of Rehabilitation Theory and Practice 2005;11(2):143-144
ObjectiveTo explore the clinical characteristics and prevention of asymptomatic bacteriuria in women patients with type 2 diabetes.MethodsThe data of 300 type 2 diabetes patients (75 with asymptomatic bacteriuria and 225 without asymptomatic bacteriuria), and 100 non diabetic controls were analyzed.ResultsThe incidence of asymptomatic bacteriuria in women patients with type 2 diabetes was 25%, and related risk factors included age, diabetes duration, level of serum glucose, hyperlipidia, diabetic neuropathy and macrovascular disease. The most frequent pathogenic agent was E. Coli.ConclusionAsymptomatic bacteriuria has a higher incidence rate in women patients with type 2 diabetes, and it maybe a part of chronic complication of diabetes.
4.Clinical observation of Batroxobin on the diabetics complicated with acute cerebral infarction
Mianrong YU ; Ruixue BAO ; Qingjiang MENG
Chinese Journal of Rehabilitation Theory and Practice 2005;11(10):797-798
ObjectiveTo observe the effect and security of Batroxobin vein injection on patients with diabetes mellitus and acute cerebral infarction.Methods66 patients with diabetes mellitus and acute cerebral infarction were treated with Batroxobin vein injection and assessed with the scale of neurological deficit before treatment and at 3rd and 6th day after treatment.At the same time the coagulant function and the count of blood platelet were measured.ResultsAfter treatment,the concentration of fibrinogen in blood plasma of patients decreased and scores of neurological deficit assessment improved both significantly(P<0.001).The total validity of Batroxobin vein injection was 93.9%.No side actions of drug were found.ConclusionBatroxobin vein injection can be used as a therapeutic method of dissolving thrombus in patients with diabetes mellitus and acute cerebral infarction in early stage.